Bacterial vaginosis affects nearly a third of women worldwide and can cause infertility, premature births and newborn deaths.

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Research reveals that treating male partners can significantly reduce bacterial vaginosis recurrence. Kidney transplant patients with diabetes benefit from GLP-1 drugs, which lower organ failure and ...

A common bacterial infection of the vagina is actually a sexually transmitted disease that can be helped by also treating male sexual partners, researchers have discovered.

A groundbreaking study shows that GLP-1 agonist anti-obesity drugs not only aid weight loss but significantly improve ...

Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative ...

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...

GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these ...